MissionIR Articles
Category: Interpace Biosciences IDXG
-
Interpace Biosciences (NASDAQ: IDXG) Growth Capacity Aided by $20 Million Investment Agreement with Major Capital Partners
Leading private equity firms 1315 Capital and Ampersand Capital Partners’ recent investment agreement with Interpace signal a “clear vote of confidence” Company’s business units, Interpace Diagnostics and Interpace Pharma Solutions, support the biotech and pharmaceutical…
Search Articles
Latest Articles
- BluSky AI Inc. (BSAI): Democratizing AI Through Modular Infrastructure and a New Neocloud That Scales from Startup to Enterprise
- MissionIRNewsBreaks – Solowin Holdings (NASDAQ: SWIN) Integrates Chainlink Data Services Into Tokenized Money Market Fund
- Brera Holdings PLC (NASDAQ: BREA) Gains Outperform Rating from PartnerCap Securities, Price Target Set at $11.50
- MissionIRNewsBreaks – Lantern Pharma Inc. (NASDAQ: LTRN) Advances Predictive Power in Cancer Drug Development
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Positioned to Drive RapidSX(TM) Toward Commercial Launch